These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 3274800)
1. Rejection of allogeneic lymphocytes and heart allografts from the same donor is mediated by different mechanisms. Orlewska E; Olszewski WL Transplant Proc; 1987 Feb; 19(1 Pt 1):437-8. PubMed ID: 3274800 [No Abstract] [Full Text] [Related]
2. Allogeneic lymphocytes are rejected by DST-pretreated, CyA-treated rats with accepted heart allograft from the same donor in a hyperacute fashion. Olszewski WL; Orlewska E; Ryffa T; Podgorska D Transplant Proc; 1990 Aug; 22(4):1985-6. PubMed ID: 2389503 [No Abstract] [Full Text] [Related]
3. Different mechanisms of rejection of organ and cell allografts. Olszewski WL; Jasklowska-Englisz M; Lukomska B Transplant Proc; 1996 Dec; 28(6):3444-6. PubMed ID: 8962343 [No Abstract] [Full Text] [Related]
4. Intrathymic injection of alloantigen may lead to hyperacute rejection and prolonged graft survival of heart allografts in the rat. de Bruin RW; van Rossum TJ; Scheringa M; Bonthuis F; IJzermans JN; Marquet RL Transplantation; 1995 Nov; 60(9):1061-3. PubMed ID: 7491686 [No Abstract] [Full Text] [Related]
5. Donor-specific transfusions prolong heart allograft survival but lymphocytes from the same donor are acutely rejected. Jaskłowska-Englisz M; Olszewski WL Transplant Proc; 1994 Dec; 26(6):3463. PubMed ID: 7998224 [No Abstract] [Full Text] [Related]
6. Prolonged survival of hepatic and cardiac allografts by i.v. injection of donor spleen cells following splenectomy in rats: possible mechanisms involved in tolerance induced by intraportal injection of donor antigens. Nagano H; Monden M; Gotoh M; Tanigawa T; Nakano Y; Tono T; Mori T Transplant Proc; 1993 Feb; 25(1 Pt 1):352-3. PubMed ID: 8438331 [No Abstract] [Full Text] [Related]
7. Allogeneic lymphocytes are rejected in hyperacute fashion by enhanced rats bearing a heart allograft from the same donor. Olszewski WL; Orlewska E; Ryffa T Transplant Proc; 1989 Feb; 21(1 Pt 1):244-5. PubMed ID: 2650111 [No Abstract] [Full Text] [Related]
9. Modified graft rejection by transfusion of the donor: a role for dendritic cells. Heineman E; Bouwman E; Marquet RL; Jeekel J Transplant Proc; 1987 Feb; 19(1 Pt 2):1470-2. PubMed ID: 3274358 [No Abstract] [Full Text] [Related]
10. Portal tolerance in rats: effect of donor cell treatment and timing of administration. Tanigawa T; Monden M; Nagano H; Hasuike Y; Gotoh M; Fukuzaki T; Ota H; Yoshida T; Mori T Transplant Proc; 1994 Aug; 26(4):1870-1. PubMed ID: 8066608 [No Abstract] [Full Text] [Related]
11. A comparison of the in vitro and in vivo immunologic activities of concanavalin A and its succinylated derivative. Morris RE; Hoyt G; DeValeria P Transplant Proc; 1987 Feb; 19(1 Pt 1):626-7. PubMed ID: 3274830 [No Abstract] [Full Text] [Related]
12. Donor-specific transfusion does not mitigate but accelerates rejection of intravenously transplanted lymphocytes. Jaskłowska-Englisz M; Podgórska D; Adamczyk G; Olszewski WL Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):365-71. PubMed ID: 8010878 [TBL] [Abstract][Full Text] [Related]
13. Differential in vivo function of splenocytes and lymphocytes harvested from rejecting allografts. Heidecke CD; Brauer R; Schneider-Eicke J; Schatschneider S; Stadler J Transplant Proc; 1989 Feb; 21(1 Pt 1):184-5. PubMed ID: 2650103 [No Abstract] [Full Text] [Related]
14. Prolonged survival of rat cardiac allografts induced by intrathymic injection of donor bone marrow cells. Matsuura T; Hara Y; Imanishi M; Kanda H; Kurita T Transplant Proc; 1993 Dec; 25(6):3283-5. PubMed ID: 8266544 [No Abstract] [Full Text] [Related]
15. Elucidation of rejection mechanisms using the splenocyte injection model in concordant xenotransplantation. Yasutomi M; Hayashi S; Ohtsuka S; Namii Y; Ito M; Uchida K; Yokoyama I; Takagi H Transplant Proc; 1995 Apr; 27(2):1583-4. PubMed ID: 7725417 [No Abstract] [Full Text] [Related]
16. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection. Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571 [TBL] [Abstract][Full Text] [Related]
17. Donor-specific tolerance to cardiac, but not renal, allografts is induced by intrathymic transfer of donor splenocytes. Nakafusa Y; Goss JA; Flye MW Transplant Proc; 1993 Feb; 25(1 Pt 1):292-4. PubMed ID: 8438305 [No Abstract] [Full Text] [Related]
18. Different response of intestinal and cardiac allografts to pretreatment with UV-B irradiated donor-specific leukocytes (DL) or DL alone. Gundlach M; Oluwole SF; Pohland CC; Broelsch CE; Hardy MA Transplant Proc; 1996 Oct; 28(5):2482-3. PubMed ID: 8907913 [No Abstract] [Full Text] [Related]
20. The different influences of allosensitization and xenosensitization on cellular rejection. Fryer JP; Chen S; Johnson EM; Sun LH; Matas AJ Transplant Proc; 1996 Apr; 28(2):674. PubMed ID: 8623338 [No Abstract] [Full Text] [Related] [Next] [New Search]